婚姻状况与早期黑色素瘤就诊时T分期及管理的关联
这项基于监测、流行病学和最终结果(SEER)数据库的回顾性人群研究纳入52 063例无区域或远处转移的皮肤黑色素瘤患者,分析婚姻状况与就诊时临床T分期及前哨淋巴结活检(SLNB)的关系。结果显示未婚、离婚和丧偶患者就诊时T分期更高,且对于Breslow厚度大于1 mm的病变,接受SLNB的可能性低于已婚患者。
要点
- 未婚、离婚和丧偶患者就诊时T分期高于已婚患者。
- 调整社会经济和患者因素后,未婚、离婚和丧偶与更高T分期仍显著相关。
- 对于Breslow厚度大于1 mm的病变,未婚、离婚和丧偶患者接受SLNB的可能性低于已婚患者。
核心结论
- 婚姻状况与局限性黑色素瘤更早就诊相关,且未婚、离婚和丧偶患者对于合适病变接受SLNB的可能性更低。
研究设计与样本
- 回顾性、基于人群的研究,使用监测、流行病学和最终结果(SEER)数据库18个基于人群的注册癌症机构的数据。
- 纳入2010年1月1日至2014年12月31日就诊的至少18岁、无区域或远处转移证据的皮肤黑色素瘤患者,共52 063例(58.8%男性,41.2%女性;中位年龄64岁,四分位距52-75岁)。
- 数据分析时间为2017年9月27日至12月5日。
主要发现
- 已婚患者中16 603例(45.7%)就诊时为T1a期,未婚患者3253例(43.0%)、离婚患者1422例(39.0%)、丧偶患者1461例(32.2%)就诊时为T1a期(P < .001)。
- 丧偶患者中428例(9.4%)就诊时为T4b期,已婚患者中1188例(3.3%)就诊时为T4b期(P < .001)。
- 调整各种社会经济和患者因素后,婚姻状况与更高就诊T分期的关联在未婚(OR 1.32;95% CI 1.26-1.39;P < .001)、离婚(OR 1.38;95% CI 1.30-1.47;P < .001)和丧偶(OR 1.70;95% CI 1.60-1.81;P < .001)患者中仍显著。
- 独立于T分期和其他患者因素,对于Breslow厚度大于1 mm、常规推荐SLNB的病变,已婚患者比未婚(OR 0.59;95% CI 0.53-0.65;P < .001)、离婚(OR 0.87;95% CI 0.76-0.99;P = .03)和丧偶(OR 0.69;95% CI 0.62-0.76;P < .001)患者更可能接受SLNB。
临床怎么用
- 作者认为,在为患者咨询黑色素瘤操作以及推荐筛查和随访以优化患者护理时,应考虑婚姻状况。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Early detection of melanoma is associated with improved patient outcomes. Data suggest that spouses or partners may facilitate detection of melanoma before the onset of regional and distant metastases. Less well known is the influence of marital status on the detection of early clinically localized melanoma. OBJECTIVE: To evaluate the association between marital status and T stage at the time of presentation with early-stage melanoma and the decision for sentinel lymph node biopsy (SLNB) in appropriate patients. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, population-based study used the Surveillance, Epidemiology, and End Results database of 18 population-based registered cancer institutes. Patients with cutaneous melanoma who were at least 18 years of age and without evidence of regional or distant metastases and presented from January 1, 2010, through December 31, 2014, were identified for the study. Data were analyzed from September 27 to December 5, 2017. EXPOSURE: Marital status, categorized as married, never married, divorced, or widowed. MAIN OUTCOMES AND MEASURES: Clinical T stage at presentation and performance of SLNB for lesions with Breslow thickness greater than 1 mm. RESULTS: A total of 52 063 patients were identified (58.8% men and 41.2% women; median age, 64 years; interquartile range, 52-75 years). Among married patients, 16 603 (45.7%) presented with T1a disease, compared with 3253 never married patients (43.0%), 1422 divorced patients (39.0%), and 1461 widowed patients (32.2%) (P < .001). Conversely, 428 widowed patients (9.4%) presented with T4b disease compared with 1188 married patients (3.3%) (P < .001). The association between marital status and higher T stage at presentation remained significant among never married (odds ratio [OR], 1.32; 95% CI, 1.26-1.39; P < .001), divorced (OR, 1.38; 95% CI, 1.30-1.47; P < .001), and widowed (OR, 1.70; 95% CI, 1.60-1.81; P < .001) patients after adjustment for various socioeconomic and patient factors. Independent of T stage and other patient factors, married patients were more likely to undergo SLNB in lesions with Breslow thickness greater than 1 mm, for which SLNB is routinely recommended, compared with never married (OR, 0.59; 95% CI, 0.53-0.65; P < .001), divorced (OR, 0.87; 95% CI, 0.76-0.99; P = .03), and widowed (OR, 0.69; 95% CI, 0.62-0.76; P < .001) patients. CONCLUSIONS AND RELEVANCE: Marital status is associated with earlier presentation of localized melanoma. Moreover, never married, divorced, and widowed patients are less likely to undergo SLNB for appropriate lesions. Marital status should be considered when counseling patients for melanoma procedures and when recommending screening and follow-up to optimize patient care.
引用
- Sharon CE, Sinnamon AJ, Ming ME, et al. Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma. JAMA Dermatol. 2018. PMID: 29710174. doi:10.1001/jamadermatol.2018.0233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。